Mackenzie Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Mackenzie Financial’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$46.3K	Buy	+37,632	New	+$60.1K	﹤0.01%	1512
2025 Q1	–	Sell	-47,792	Closed	-$238K	–	1671
2024 Q4	$238K	Buy	47,792 +36,160	+311%	+$186K	﹤0.01%	1483
2024 Q3	$62.7K	Sell	11,632 -3,392	-23%	-$16.1K	﹤0.01%	1524
2024 Q2	$49.7K	Sell	15,024 -493	-3%	-$1.93K	﹤0.01%	1492
2024 Q1	$50.7K	Buy	+15,517	New	+$51K	﹤0.01%	1482

Other funds holding ALDX

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 22.25% 1-Year Est. Return

Providence Wealth Advisors Frankfort, Illinois $174M AUM 29.13% 1-Year Est. Return

Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.25% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mackenzie Financial's ALDX Position: Q3 2026 in Review

Mackenzie Financial opened a new position in Aldeyra Therapeutics (ALDX) in Q3 2026: 37,632 shares worth $46.3K. The stake represents ﹤0.01% of the portfolio and ranks #1512 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in ALDX as recently as Q4 2024.

Mackenzie Financial first reported a position in ALDX in Q1 2024 and has held it in 5 quarters since. The position peaked at $238K in Q4 2024. 21 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

Mackenzie Financial held 37,632 shares of Aldeyra Therapeutics worth $46.3K as of Q3 2026.
Aldeyra Therapeutics was a new Mackenzie Financial position in Q3 2026.
Aldeyra Therapeutics made up ﹤0.01% of Mackenzie Financial's portfolio in Q3 2026, its #1512 holding.
Mackenzie Financial first reported a position in Aldeyra Therapeutics in Q1 2024 and has held it in 5 quarters since.
Mackenzie Financial's Aldeyra Therapeutics position peaked at $238K in Q4 2024.
21 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Mackenzie Financial's 13F filing for Q3 2026, filed 2 Nov 2026.